Zusammenfassung
Leptin wurde primär als Hormon beschrieben, welches eine kritische Funktion in der
Regulation der Nahrungsaufnahme sowie Adaption an Nahrungszustände, wie beispielsweise
Fasten einnimmt. In der vorliegenden Übersichtsarbeit soll auf eine neue Rolle von
Leptin eingegangen werden: die Position von Leptin im Immunsystem. Es werden hierbei
die strukturellen Besonderheiten von Leptin beschrieben, die bereits auf eine Mediatorfunktion
im Immunsystem hindeuten, sowie auf die Leptin-abhängigen Veränderungen einzelner
Zellpopulationen des Immunsystems. Unterstützt werden diese in vitro-Daten durch in vivo-Untersuchungen in verschiedenen Tiermodellen sowie deskriptiven und funktionellen
Daten von Leptin-defizienten Menschen, die ausführlich dargelegt sind. Leptin in seiner
chimären Funktion als Hormon und Zytokin/Adipokin stellt somit exemplarisch eine Verbindung
zwischen der Immunologie und Endokrinologie dar, welche neue pathophysiologische Zusammenhänge
und damit therapeutische Optionen eröffnet.
Summary
Leptin is primarily known as a hormone regulating food intake and the adjustment to
a distinct state of nutrition. In the present work a new function of leptin will be
described, namely the role of leptin in the immune system. Structural characteristics
of leptin and the leptin receptor already suggest an immune modulatory function. The
effect of leptin on the various populations of immune cells in vitro will be described. These data are supported by findings obtained in in vivo animal models as well as descriptive and functional data from leptin-deficient humans
which will be outlined in detail. In conclusion, the chimeric function of leptin as
hormone and a cytokine/adipokine represents a unique link between the immune and the
endocrine system thus opening a new field of research and therapeutic options.
Literatur
- 1
Ahima R S, Prabakaran D, Mantzoros C. et al .
Role of leptin in the neuroendocrine response to fasting.
Nature.
1996;
382
250-252
- 2
Banks A S, Davis S M, Bates S H, Myers M G.
Activation of downstream signals by the long form of the leptin receptor.
J Biol Chem.
2000;
275
14 563-14 572
- 3
Bernotiene E, Palmer G, Talabot-Ayer D, Szalay-Quinodoz I, Aubert M L, Gabay C.
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient
mice.
Arthritis Res Ther.
2004;
6
R256-263
- 4
Busso N, So A, Chobaz-Peclat V. et al .
Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates
experimental arthritis.
J Immunol.
2002;
168
875-882
- 5
Coleman D L.
Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice.
Diabetologia.
1978;
14
141-148
- 6
Devos R, Guisez Y, Van der Heyden J. et al .
Ligand-independent dimerization of the extracellular domain of the leptin receptor
and determination of the stoichiometry of leptin binding.
J Biol Chem.
1997;
272
18 304-18 310
- 7
Dixit V D, Mielenz M, Taub D D, Parvizi N.
Leptin induces growth hormone secretion from peripheral blood mononuclear cells via
a protein kinase C- and nitric oxide-dependent mechanism.
Endocrinology.
2003;
144
5595-603
- 8
Faggioni R, Jones-Carson J, Reed D A. et al .
Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role
of tumor necrosis factor alpha and IL-18.
Proc Natl Acad Sci U S A.
2000;
97
2367-2372
- 9
Fantuzzi G, Faggioni R.
Leptin in the regulation of immunity, inflammation, and hematopoiesis.
J Leukoc Biol.
2000;
68
437-446
- 10
Farooqi I S, Matarese G, Lord G M. et al .
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic
dysfunction of human congenital leptin deficiency.
J Clin Invest.
2002;
110
1093-1103
- 11
Fong T M, Huang R R, Tota M R. et al .
Localization of leptin binding domain in the leptin receptor.
Mol Pharmacol.
1998;
53
234-240
- 12
Gainsford T, Willson T A, Metcalf D. et al .
Leptin can induce proliferation, differentiation, and functional activation of hemopoietic
cells.
Proc Natl Acad Sci U S A.
1996;
93
14 564-14 568
- 13
Hardwick J CH, Van den Brink G R, Offerhaus G J, Van Deventer S JH, Peppelenbosch M P.
Leptin is a growth factor for colonic epithelial cells.
Gastroenterology.
2001;
121
79-90
- 14
Hileman S M, Tornoe J, Flier J S, Bjorbaek C.
Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby
Canine Kidney cells.
Endocrinology.
2000;
141
1955-1961
- 15
Huang L, Wang Z, Li C.
Modulation of circulating leptin levels by its soluble receptor.
J Biol Chem.
2001;
276
6343-6349
- 16
La Cava A, Matarese G.
The weight of leptin in immunity.
Nat Rev Immunol.
2004;
4
371-379
- 17
Lord G M, Matarese G, Howard J K, Baker R J, Bloom S R, Lechler R I.
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression.
Nature.
1998;
394
897-901
- 18
Lord G M, Matarese G, Howard J K, Bloom S R, Lechler R I.
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but
enhances the production of proinflammatory cytokines.
J Leukoc Biol.
2002;
72
330-338
- 19
Mancuso P, Gottschalk A, Phare S M, Peters-Golden M, Lukacs N W, Huffnagle G B.
Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia.
J Immunol.
2002;
168
4018-4024
- 20
Mandel M A, Mahmoud A A.
Impairment of cell-mediated immunity in mutation diabetic mice (db/db).
J Immunol.
1978;
120
1375-1377
- 21
Matarese G, Di Giacomo A, Sanna V. et al .
Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.
J Immunol.
2001;
166
5909-5916
- 22
Matarese G, Sanna V, Di Giacomo A. et al .
Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and
confers susceptibility to males.
Eur J Immunol.
2001;
31
1324-1332
- 23
Montague C T, Farooqi I S, Whitehead J P. et al .
Congenital leptin deficiency is associated with severe early-onset obesity in humans.
Nature.
1997;
387
903-908
- 24
Mykoniatis A, Anton P M, Wlk M. et al .
Leptin mediates Clostridium difficile toxin A-induced enteritis in mice.
Gastroenterology.
2003;
124
683-691
- 25
Ozata M, Ozdemir I C, Licinio J.
Human leptin deficiency caused by a missense mutation: multiple endocrine defects,
decreased sympathetic tone, and immune system dysfunction indicate new targets for
leptin action, greater central than peripheral resistance to the effects of leptin,
and spontaneous correction of leptin-mediated defects.
J Clin Endocrinol Metab.
1999;
84
3686-3695
- 26
Palacio A, Lopez M, Perez-Bravo F. et al .
Leptin levels are associated with immune response in malnourished infants.
J Clin Endocrinol Metab.
2002;
87
3040-3046
- 27
Sanchez-Margalet V, Martin-Romero C.
Human leptin signaling in human peripheral blood mononuclear cells: activation of
the JAK-STAT pathway.
Cell Immunol.
2001;
211
30-36
- 28
Sanna V, Di Giacomo A, La Cava A. et al .
Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development
of pathogenic T cell responses.
J Clin Invest.
2003;
111
241-250
- 29
Siegmund B, Lear-Kaul K C, Faggioni R, Fantuzzi G.
Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis.
Eur J Immunol.
2002;
32
552-560
- 30
Siegmund B, Lehr H A, Fantuzzi G.
Leptin: a pivotal mediator of intestinal inflammation in mice.
Gastroenterology.
2002;
122
2011-2025
- 31
Siegmund B, Sennello J A, Jones-Carson J. et al .
Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation
in mice.
Gut.
2004;
53
965-972
- 32
Strobel A, Issad T, Camoin L. et al .
A leptin missense mutation associated with hypogonadism and morbid obesity.
Nat Genet.
1998;
18
213-215
- 33
Tartaglia L A, Dembski M, Weng X. et al .
Identification and expression cloning of a leptin receptor, OB-R.
Cell.
1995;
83
1263-1271
- 34
Tartaglia L A.
The leptin receptor.
J Biol Chem.
1997;
272
6093-6096
- 35
Tarzi R M, Cook H T, Jackson I, Pusey C D, Lord G M.
Leptin-deficient mice are protected from accelerated nephrotoxic nephritis.
Am J Pathol.
2004;
164
385-390
- 36
Yang S Q, Lin H Z, Lane M D, Clemens M, Diehl A M.
Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis
of steatohepatitis.
Proc Natl Acad Sci U S A.
1997;
94
2557-2562
- 37
Zabeau L, Lavens D, Peelman F, Eyckerman S, Vandekerckhove J, Tavernier J.
The ins and outs of leptin receptor activation.
FEBS Lett.
2003;
546
45-50
- 38
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M.
Positional cloning of the mouse obese gene and its human homologue.
Nature.
1994;
372
425-432
Dr. Britta Siegmund
Medizinische Klinik I, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin
Hindenburgdamm 30
12200 Berlin
Phone: 030/84452495
Fax: 030/84454481
Email: britta.siegmund@charite.de